Delivery Order SPE2DB22D1017-SPE2DB25FG6TK

Award Date 7/7/25
Potential Completion Date 7/8/25
Potential Value $8.1K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,561.46 contract is for the delivery of AIMOVIG 140 MG/ML AUTOINJECTORML, a pharmaceutical product. The contract has an ultimate completion date of June 16, 2025. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of AIMOVIG 140 MG/ML AUTOINJECTORML. The contract has a firm fixed price of $1,544.08 and a period of performance through April 18, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) with a ceiling value of $999,999,999.00 that Amerisourcebergen holds with the DLA Troop Support Medical. The IDC, designated...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,360.46, is for the delivery of AIMOVIG 140 MG/ML AUTOINJECTORML, a medical product. This delivery order is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The $5,829.16 firm fixed-price contract is for the supply of AIMOVIG 140 MG/ML AUTOINJECTORML, a specialty pharmaceutical product. The ultimate completion date for this delivery order is October 21, 2024. The award is associated with a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $10,758.34, is for the supply of AIMOVIG 140 MG/ML AUTOINJECTORML, a prescription medication. The contract has an ultimate completion date of April 18, 2025 and is not set aside for any specific business category. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with DLA Troop...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,798.43 firm fixed-price contract is for the supply of AIMOVIG 140 MG/ML AUTOINJECTORML, with a performance period ending on May 19, 2025. The award is not set-aside and is part of AmerisourceBergen's larger $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which enables the...
This is a $13,791.16 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the medical product "AIMOVIG 140 MG/ML AUTOINJECTORML" and has a completion date of June 18, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive...
This is a Firm Fixed Price Delivery Order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,995.81, provides for the delivery of AIMOVIG 140 MG/ML AUTOINJECTORML, a specialty medication, with a performance period through March 2024. This Delivery Order is under a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of AIMOVIG 140 MG/ML AUTOINJECTORML, a pharmaceutical product, with a ceiling value of $1,017.58 and a performance period ending on June 24, 2025. The contract is a firm-fixed-price delivery order, with no set-aside designation. AmerisourceBergen Drug Corp holds a...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for the supply of AIMOVIG 140 MG/ML AUTOINJECTORML. The contract has a ceiling value of $31,305.20 and is a firm fixed price, non-set-aside delivery order with a period of performance through May 19, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
  • SPE2DB22D1017
    Indefinite Delivery Contract
  • SPE2DB22D1017-SPE2DB25FG6TK
    Delivery Order

This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $8,140.76, is for the delivery of AIMOVIG 140 MG/ML AUTOINJECTORML, a pharmaceutical product.

The delivery order is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen Drug Corp with the DLA Troop Support Medical, valued at $999,999,999.00. This IDC provides a comprehensive global pharmaceutical support vehicle for the delivery of a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, including the Defense Health Agency and U.S. Coast Guard.

The contract is a firm fixed-price delivery order with a completion date of July 8, 2025. It is not designated as a set-aside contract, indicating open competition.

Generated 10/6/25, 12:44 PM